首页 | 本学科首页   官方微博 | 高级检索  
     

愈肝方联合熊去氧胆酸治疗原发性胆汁性肝硬化临床疗效分析
引用本文:张宁,刘红虹,孙永强,宫墁,张彼,吴欣,罗生强. 愈肝方联合熊去氧胆酸治疗原发性胆汁性肝硬化临床疗效分析[J]. 中西医结合肝病杂志, 2011, 21(4): 207-208. DOI: 10.3969/j.issn.1005-0264.2011.04.006
作者姓名:张宁  刘红虹  孙永强  宫墁  张彼  吴欣  罗生强
作者单位:中国人民解放军第302医院中西医结合肝病诊疗与研究中心,北京,100039
摘    要:
目的:观察中药愈肝方联合熊去氧胆酸(UDCA)治疗原发性胆汁性肝硬化(PBC)的临床疗效。方法:回顾性分析2007年1月-2010年12月在我院住院且符合纳入标准的PBC患者共66人,根据治疗方案不同,分为愈肝方与UDCA治疗组及UDCA治疗组,比较两组的临床疗效。结果:治疗4周后,愈肝方与UDCA组的好转率优于UDCA组,且在总胆红素、碱性磷酸酶两项主要生化指标方面均较UDCA组有显著下降。结论:愈肝方联合UDCA治疗原发性胆汁性肝硬化,较单用UDCA能更有效。

关 键 词:原发性胆汁性肝硬化  熊去氧胆酸  中药  联合治疗

Efficacy of Yuganfang combined with ursodeoxycholic acid in treatment of patients of primary biliary cirrhosis
ZHANG NING,LIU HONG-HONG,SUN YONG-QIANG,et al.. Efficacy of Yuganfang combined with ursodeoxycholic acid in treatment of patients of primary biliary cirrhosis[J]. Chinese Journal of Integrated Traditonal and Western Medicine on Liver Diseases, 2011, 21(4): 207-208. DOI: 10.3969/j.issn.1005-0264.2011.04.006
Authors:ZHANG NING  LIU HONG-HONG  SUN YONG-QIANG  et al.
Affiliation:ZHANG NING,LIU HONG-HONG,SUN YONG-QIANG,et al.Diagnosis and Treatment Research Center of Liver Disease by Integrated Traditional Chinese Medicine and Western Medicine.302 Hospital of PLA(Beijing,100039)China
Abstract:
Objective:To study the clinical efficacy of Yuganfang combined with ursodeoxycholic acid in treatment of primary biliary cirrhosis.Methods: Restrospective analysis of 66 in-patients in our hospital during January 2007 and December 2010 who meet the inclusion criteria.According the different treatment,patients were divided into two groups,Yuganfang with UDCA group and UDCA group,the efficacy of the two groups were compared.Results: The treatment of Yuganfang with UDCA could increase the improvement rates bet...
Keywords:primary biliary cirrhosis  ursodeoxycholic acid  Chinese herbs  integrated therapy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号